Peter Brenders
About Peter Brenders
Peter Brenders is the General Manager, Canada at BeiGene and President & Managing Director at TO4 Group Inc., with extensive experience in the biotech and pharmaceutical sectors.
Title and Current Roles
Peter Brenders is currently serving as the General Manager for BeiGene in Canada, based in Toronto, Ontario. In this role, he is responsible for establishing and growing BeiGene’s operations in Canada, including recruiting and developing a cross-functional team to bring new oncology therapies to Canadian patients. Additionally, he holds the position of President & Managing Director at TO4 Group Inc., also located in Toronto.
Past Leadership Experience
Peter Brenders' career includes several leadership roles across various organizations. From 2020 to 2021, he served as CEO and Executive Advisor at the New Brunswick Health Research Foundation. In 2020, he was President and CEO of Kontollo Health Inc., based in the United States. His tenure as CEO and Strategic Advisor to the Chairman at Inagene Diagnostics Inc. spanned from 2018 to 2020. He also held the role of General Manager for Sanofi Genzyme in Canada from 2012 to 2018. Prior to that, he was President and CEO of BIOTECanada between 2005 and 2012.
Educational Background and Expertise
Peter Brenders holds a BSc (Hons) in Pharmacology & Toxicology from Western University, completed between 1984 and 1988. He earned his MBA in Health Services Management from McMaster University between 1988 and 1991. Furthering his education, he also completed executive education programs in Leadership and Strategy in Pharmaceuticals and Biotech at Harvard Business School in 2010, and Leading Change and Organizational Renewal at Stanford University Graduate School of Business in 2011.
Industry Contributions and Achievements
Throughout his career, Peter Brenders has played an instrumental role in the biotech and pharmaceutical sectors. His contributions include successfully leading the launch of 18 new products across various markets and specialties. He has been involved in patient-centered care across several fields, including hematology, oncology, rare diseases, genetics, neurology, and immunology. Brenders has also contributed to several transformations in business and organizations, including mergers, and has been involved in board and advisory roles with university-affiliated research and development bodies, non-profit organizations, and for-profit businesses.
Professional Skills and Capabilities
Peter Brenders has demonstrated considerable expertise in various areas such as team building, strategic direction, and change management. His talents include authentic leadership, decisive action, and effective communication. He is also experienced in recruiting and developing team members and expanding operations. His background spans various roles in market access, corporate affairs, health economics, and health policy, providing him with a comprehensive understanding of the healthcare and pharmaceutical landscapes.